1250 related articles for article (PubMed ID: 15326102)
21. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
You JJ; Yang CH; Huang JS; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
[TBL] [Abstract][Full Text] [Related]
22. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
23. Expression pattern of fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF) system members in bovine corpus luteum endothelial cells during treatment with FGF-2, VEGF or oestradiol.
Gabler C; Plath-Gabler A; Killian GJ; Berisha B; Schams D
Reprod Domest Anim; 2004 Oct; 39(5):321-7. PubMed ID: 15367264
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.
Cornali E; Zietz C; Benelli R; Weninger W; Masiello L; Breier G; Tschachler E; Albini A; Stürzl M
Am J Pathol; 1996 Dec; 149(6):1851-69. PubMed ID: 8952523
[TBL] [Abstract][Full Text] [Related]
25. Impaired angiogenic response in the corneas of mice lacking osteopontin.
Fujita N; Fujita S; Okada Y; Fujita K; Kitano A; Yamanaka O; Miyamoto T; Kon S; Uede T; Rittling SR; Denhardt DT; Saika S
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):790-4. PubMed ID: 19741245
[TBL] [Abstract][Full Text] [Related]
26. Nuclear factor kappaB dependency of platelet-activating factor-induced angiogenesis.
Ko HM; Seo KH; Han SJ; Ahn KY; Choi IH; Koh GY; Lee HK; Ra MS; Im SY
Cancer Res; 2002 Mar; 62(6):1809-14. PubMed ID: 11912159
[TBL] [Abstract][Full Text] [Related]
27. The induction of an angiogenic response in corneal myofibroblasts by platelet-activating factor (PAF).
He J; Eastlack JP; Bazan HE
Curr Eye Res; 2010 Dec; 35(12):1063-71. PubMed ID: 20961214
[TBL] [Abstract][Full Text] [Related]
28. A siRNA targeting vascular endothelial growth factor-A inhibiting experimental corneal neovascularization.
Zuo L; Fan Y; Wang F; Gu Q; Xu X
Curr Eye Res; 2010 May; 35(5):375-84. PubMed ID: 20450250
[TBL] [Abstract][Full Text] [Related]
29. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.
Duh EJ; Yang HS; Suzuma I; Miyagi M; Youngman E; Mori K; Katai M; Yan L; Suzuma K; West K; Davarya S; Tong P; Gehlbach P; Pearlman J; Crabb JW; Aiello LP; Campochiaro PA; Zack DJ
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):821-9. PubMed ID: 11867604
[TBL] [Abstract][Full Text] [Related]
30. Human IL-3 stimulates endothelial cell motility and promotes in vivo new vessel formation.
Dentelli P; Del Sorbo L; Rosso A; Molinar A; Garbarino G; Camussi G; Pegoraro L; Brizzi MF
J Immunol; 1999 Aug; 163(4):2151-9. PubMed ID: 10438956
[TBL] [Abstract][Full Text] [Related]
31. Tumor growth, angiogenesis and inflammation in mice lacking receptors for platelet activating factor (PAF).
Ferreira MA; Barcelos LS; Teixeira MM; Bakhle YS; Andrade SP
Life Sci; 2007 Jun; 81(3):210-7. PubMed ID: 17588613
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effect of curcumin on corneal neovascularization in vitro and in vivo.
Bian F; Zhang MC; Zhu Y
Ophthalmologica; 2008; 222(3):178-86. PubMed ID: 18497527
[TBL] [Abstract][Full Text] [Related]
33. Platelet-activating factor (PAF) induces activation of matrix metalloproteinase 2 activity and vascular endothelial cell invasion and migration.
Axelrad TW; Deo DD; Ottino P; Van Kirk J; Bazan NG; Bazan HE; Hunt JD
FASEB J; 2004 Mar; 18(3):568-70. PubMed ID: 14715700
[TBL] [Abstract][Full Text] [Related]
34. PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis.
Bussolati B; Biancone L; Cassoni P; Russo S; Rola-Pleszczynski M; Montrucchio G; Camussi G
Am J Pathol; 2000 Nov; 157(5):1713-25. PubMed ID: 11073830
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of neuropilin-1 by basic fibroblast growth factor enhances vascular smooth muscle cell migration in response to VEGF.
Liu W; Parikh AA; Stoeltzing O; Fan F; McCarty MF; Wey J; Hicklin DJ; Ellis LM
Cytokine; 2005 Dec; 32(5):206-12. PubMed ID: 16289960
[TBL] [Abstract][Full Text] [Related]
36. Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterus.
Hervé MA; Meduri G; Petit FG; Domet TS; Lazennec G; Mourah S; Perrot-Applanat M
J Endocrinol; 2006 Jan; 188(1):91-9. PubMed ID: 16394178
[TBL] [Abstract][Full Text] [Related]
37. Alkali-induced corneal neovascularization is independent of CXCR2-mediated neutrophil infiltration.
Lu P; Li L; Mukaida N; Zhang X
Cornea; 2007 Feb; 26(2):199-206. PubMed ID: 17251813
[TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing.
Gan L; Fagerholm P; Palmblad J
Acta Ophthalmol Scand; 2004 Oct; 82(5):557-63. PubMed ID: 15453853
[TBL] [Abstract][Full Text] [Related]
39. Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist.
Lu P; Li L; Liu G; Zhang X; Mukaida N
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4761-8. PubMed ID: 19458323
[TBL] [Abstract][Full Text] [Related]
40. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
